Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973379-25-000081
Filing Date
2025-03-04
Accepted
2025-03-04 19:55:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4899
  Complete submission text file 0001973379-25-000081.txt   6317
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Subject) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36815 | Film No.: 25707967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ASCENDIS PHARMA A/S TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address
JENSEN MICHAEL WOLFF (Reporting) CIK: 0001965622 (see all company filings)

Type: 144